Brief: TetraLogic Pharma says has an open U.S. IND application in support of phase 2 clinical trial of suberohydroxamic acid phenyl ester

Tetralogic Pharmaceuticals

02/11/2015 12:04

Nov 2 (Reuters) - TetraLogic Pharmaceuticals Corp  TLOG.O : 
 * Has open U.S. ind application in support of phase 2 clinical trial of 
   suberohydroxamic acid phenyl ester 
 * Source text for Eikon  urn:newsml:reuters.com:*:nGNXVESSBa 
 * Further company coverage  TLOG.O   
 
 ((Bengaluru Newsroom; +1 646 223 8780))